Effects of paroxetine on emotional functioning and treatment awareness: A 4-week randomized placebo-controlled study in healthy clinicians

Psychopharmacology

Volumn 207, Issue 4, 2010, Pages 619-629

  Besnier, Nathalie ^a,b   Cassé Perrot, Catherine ^b,c   Jouve, Elisabeth ^b,c   Nguyen, Nhan ^b,c   Lançon, Christophe ^a   Falissard, Bruno ^d   Blin, Olivier ^b,c  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b Institut de Neurosciences Cognitives de la Méditerranée   (France)

^c TIMONE HOSPITAL   (France)

^d Institut Cochin   (France)

Author keywords

Emotion processing; Human; Paroxetine; Placebo effect; SSRI

Indexed keywords

PAROXETINE; PLACEBO;

ADULT; ARTICLE; AWARENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EMOTION; EMOTIONAL STATE QUESTIONNAIRE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOLOGIST; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; AWARENESS; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SEX FACTORS; SINGLE-BLIND METHOD;

EID: 72049092932     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1691-4     Document Type: Article

References (39)

1. Agosti V, McGrath PJ (2002) Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression. J Affect Disord 71:113-120 (Pubitemid 34886416)
2. Attenburrow MJ, Williams C, Odontiadis J, Reed A, Powell J, Cowen PJ, Harmer CJ (2003) Acute administration of nutritionally sourced tryptophan increases fear recognition. Psychopharmacology 169:104-107 (Pubitemid 37088620)
3. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152 (Pubitemid 29292403)
4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 41:53-63
5. Boz C, Gazioglu S, Altunayoglu V, Hocaoglu C (2007) Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache. Psychiatry Clin Neurosci 61:534-542 (Pubitemid 47414856)
6. Bradford HA (1951) The clinical trial. Br Med Bull 7:278-282
7. Browning M, Reid C, Cowen PJ, Goodwin GM, Harmer CJ (2007) A single dose of citalopram increases fear recognition in healthy subjects. J Psychopharmacol 21:684-690 (Pubitemid 47437913)
8. Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, LeDoux JE (2004) The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 55:1171-1178
9. Burish TG, Snyder SL, Jenkins RA (1991) Preparing patients for cancer chemotherapy: effect of coping preparation and relaxation interventions. J Consult Clin Psychol 59(4):518-525 9
10. Bush G, Luu P, Posner MI (2000) Cognitive and emotional influences in anterior cingulate cortex. Trends Cognit Sci 4:215-222 (Pubitemid 30332147)
11. Cassé-Perrot C, Fakra E, Jouve E, Blin O (2007) Conceptualisation and Validation of the "Emotional State Questionnaire (ESQ)": evaluation of an emotional profile. L'Encéphale 33:169-178
12. Cloninger CR, Svrakic DM, Przybeck TR (1993) A psychobiological model of temperament and character. Arch Gen Psychiatry 50:975-990
13. Dichter GS, Tomarken AJ, Freid CM, Addington S, Shelton RC (2005) Do venlafaxine XR and paroxetine equally influence negative and positive affect? J Affect Disord 85:333-339
14. Drevets WC, Raichle M (1998) Reciprocal suppression of regional cerebral blood flow during emotional versus higher cognitive processes: implications for interactions between emotion and cognition. Cognit Emotion 12:353-385
15. Enck P, Zipfel S, Klosterhalfen S (2009) The placebo effect in medicine. Physiol Behav 97(1):102-106
16. Enck P, Benedetti F, Schedlowski M (2008) New insights into the placebo and nocebo responses. Neuron 59(2):195-206 31
17. Geers AL, Weiland PE, Kosbab K, Landry SJ, Helfer SG (2005) Goal activation, expectations, and the placebo effect. J Pers Soc Psychol 89(2):143-159 (Pubitemid 41356483)
18. Goldstein BJ, Goodnick PJ (1998) Selective serotonin reuptake inhibitors in the treatment of affective disorders: III. Tolerability, safety and pharmacoeconomics. J Psychopharmacol 12(Suppl B): S55-87
19. Goodnick PJ, Goldstein BJ (1998) Selective serotonin reuptake inhibitors in affective disorders - II. Efficacy and quality of life. J Psychopharmacol 12(Suppl B):S21-54
20. Harmer CJ, Bhagwagar Z, Perrett DI, Völlm BA, Cowen PJ, Goodwin GM (2003a) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28:148-152
21. Harmer CJ, Rogers RD, Tunbridge E, Cowen PJ, Goodwin GM (2003b) Tryptophan depletion decreases the recognition of fear in female volunteers. Psychopharmacology 167:411-417 (Pubitemid 36754243)
22. Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161:1256-1263
23. Kemp AH, Gray MA, Silberstein RB, Armstrong SM, Nathan PJ (2004) Augmentation of serotonin enhances pleasant and unpleasant cortical electrophysiological responses to visual emotional stimuli in humans. NeuroImage 22:1084-1096
24. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC, Terpstra J, Turner RA, Reus VI (1998) Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 155:373-379 (Pubitemid 28114895)
25. Li H, Yuan J, Lin C (2008) The neural mechanism underlying the female advantage in identifying negative emotions: an event-related potential study. Neuroimage 40:1921-1929
26. Marijnissen G, Tuinier S, Sijben AE, Verhoeven WM (2002) The temperament and character inventory in major depression. J Affect Disord 70:219-223 (Pubitemid 34765565)
27. Mörtberg E, Bejerot S, Aberg Wistedt A (2007) Temperament and character dimensions in patients with social phobia: patterns of change following treatments? Psychiatry Res 152:81-90. doi:10.1016/j.psychres.2006.10. 003
28. Parsey RV, Kegeles LS, Hwang DR, Simpson N, Abi-Dargham A, Mawlawi O, Slifstein M, Van Heertum RL, Mann JJ, Laruelle M (2000) In vivo quantification of brain serotonin transporters in humans using [11C]McN 5652. Nucl Med 41:1465-1477
29. Paul MA, Gray GW, Love RJ, Lange M (2007) SSRI effects on pyschomotor performance: assessment of citalopram and escitalopram on normal subjects. Aviat Space Environ Med 78:693-697
30. Phillips ML, Drevets WC, Rauch SL, Lane R (2003) Neurobiology of emotion perception I: the neural basis of normal emotion perception. Biol Psychiatry 54:504-514 (Pubitemid 37289437)
31. Radloff LS (1977) The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas 1:385-401
32. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, Schwartz J, Miyawaki E (1995) Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 15:23-29
33. Serra M, Salgado-Pineda P, Delaveau P, Fakra E, Gasto C, Blin O (2006) Effects of antidepressant drugs on emotion. Clin Neuropharmacol 29:170-185
34. Spielberger CD (1983) State-Trait Anxiety Inventory a comprehensive bibliography. Consulting Psychologists, Palo Alto
35. SteinerM, Steinberg S, Stewart D, Carter D, Berger C, Reid R, Grover D, Streiner D (1995) Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med 332:1529-1534
36. Tse WS, Bond AJ (2001) Serotonergic involvement in the psychosocial dimension of personality. J Psychopharmacol 15:195-198
37. Wadsworth EJ, Moss SC, Simpson SA, Smith AP (2005) SSRIs and cognitive performance in a working sample. Hum Psychopharmacol 20:561-572
38. Warot D, Danjou P, Payan C, Puech AJ (1997) Sensitivity and specificity to amphetamine of a french version of the 49-item form of the addiction research center inventory. Drug Alcohol Depend 45:177-183 (Pubitemid 27232156)
39. Wellman CL, Izquierdo A, Garrett JE, Martin KP, Carroll J, Millstein R, Lesch KP, Murphy DL, Holmes A (2007) Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci 27:684-691 (Pubitemid 46143772)